Taken together, we presented an overall picture of lincRNA alterations in cisplatin-resistant progression, and explored the mechanism associated with H19 involvement in this process, which offers new insight into H19 function in ovarian cancer chemotherapy resistance and explores new methods for improving the efficiency of cancer chemotherapy. The gene discussed is H19; the disease is cancer.